News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,229 Results
Type
Article (5028)
Company Profile (17)
Press Release (220184)
Section
Business (82219)
Career Advice (461)
Deals (15045)
Drug Delivery (8)
Drug Development (19066)
Employer Resources (30)
FDA (3678)
Job Trends (3902)
News (120129)
Policy (7503)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14778)
ALS (20)
Alzheimer's disease (248)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (446)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16029)
Collaboration (169)
Compensation (169)
Complete response letters (2)
COVID-19 (302)
CRISPR (7)
C-suite (104)
Cystic fibrosis (16)
Data (513)
Depression (5)
Diabetes (42)
Diagnostics (2040)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40824)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37769)
Executive appointments (311)
FDA (3929)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (108)
Government (411)
Guidances (17)
Healthcare (5036)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (318)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (101)
Leadership (5)
Legal (2333)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (49)
MASH (28)
Medical device (3867)
Medtech (3868)
Mergers & acquisitions (7428)
Metabolic disorders (122)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (341)
NextGen: Class of 2025 (1674)
Non-profit (728)
Northern California (927)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (21)
Patient recruitment (29)
Peanut (5)
People (24597)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4777)
Phase II (6961)
Phase III (5548)
Pipeline (552)
Policy (9)
Postmarket research (625)
Preclinical (1872)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5114)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (700)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (4)
United States (7031)
Vaccines (37)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Last 7 days (174)
Last 30 days (653)
Last 365 days (9948)
2025 (2993)
2024 (11029)
2023 (13198)
2022 (18661)
2021 (19681)
2020 (18241)
2019 (13217)
2018 (10212)
2017 (10006)
2016 (9163)
2015 (12118)
2014 (9588)
2013 (7710)
2012 (8333)
2011 (8797)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11458)
Australia (1608)
California (1943)
Canada (698)
China (71)
Colorado (82)
Connecticut (91)
Delaware (29)
Europe (24511)
Florida (275)
Georgia (33)
Idaho (23)
Illinois (112)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (221)
Massachusetts (1552)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (558)
New Mexico (5)
New York (470)
North Carolina (327)
North Dakota (2)
Northern California (927)
Ohio (56)
Oklahoma (5)
Oregon (4)
Pennsylvania (345)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (700)
Tennessee (40)
Texas (228)
Utah (60)
Virginia (46)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (22)
225,229 Results for "animas corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anima Research receives investment from BNP Paribas Fortis Private Equity to support expansion of its industry-leading clinical trials business in Europe
December 3, 2024
·
3 min read
Business
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
AbbVie (NYSE: ABBV), and Anima Biotech (Anima), today announced a collaboration to discover and develop mRNA biology modulators for three targets across Oncology and Immunology.
January 10, 2023
·
5 min read
Business
AbbVie, Anima Strike mRNA Deal Worth Up to $582M
Tuesday, AbbVie partnered with Anima Biotech to discover and develop mRNA modulators in a collaboration of up to $582 million. The partnership will focus on three oncology and immunology targets.
January 10, 2023
·
2 min read
·
Tristan Manalac
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Lobe Sciences Provides Corporate Update
April 7, 2025
·
8 min read
Press Releases
Quantum BioPharma Provides Corporate Update
March 31, 2025
·
4 min read
1 of 22,523
Next
